Longitudinal behavioral and 6-[18F]fluoro-L-DOPA-PET assessment in MPTP-hemiparkinsonian monkeys

Experimental Neurology

Volumn 141, Issue 2, 1996, Pages 318-329

  Melega, William P ^a   Raleigh, Michael J ^a,b   Stout, David B ^a   DeSalles, Antonio A ^a   Cherry, Simon R ^a   Blurton Jones, Matthew ^a   Morton, Grenvill G ^b   Huang, Sung Cheng ^a   Phelps, Michael E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 6 FLUORODOPA F 18; CARBIDOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; MONKEY; NONHUMAN; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030272412     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0167     Document Type: Article

References (35)

1. 1. ALEXANDER, G. M., R. J. SCHWARTZMAN, L. BRAINARD, S. W. GORDON, AND J. R. GROTHUSEN. 1992. Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys. Brain Res. 588: 261-269.
2. 2. BANKIEWICZ, K. S., E. H. OLDPIELD, C. C. CHIEUH, J. L. DOPPMAN, D. M. JACOBOWITZ, AND I. J. KOPIN. 1986. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci. 39: 7-16.
3. 3. BROOKS, B. A., E. EIDELBERG, AND W. W. MORGAN. 1987. Behavioral and biochemical studies in monkeys made hemiparkinsonian by MPTP. Brain Res. 419: 329-332.
4. 4. GUMMING, P., B. E. BOYES, W. R. MARTIN, M. ADAM, J. GRIERSON, T. J. RUTH, AND E. G. MCGEER. 1987. The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat. J. Neurochem. 48: 601-608.
5. 5. CUTLER, P. D., S. R. CHERRY, E. J. HOFFMAN, W. M. DIGBY, AND M. E. PHELPS. 1992. Design features and performance of a PET system for animal research. J. Nucl. Med. 33: 595-604.
6. 6. EIDELBERG, E., B. A. BROOKS, W. W. MORGAN, J. G. WALDEN, AND R. H. KOKEMOOR. 1986. Variability and functional recovery in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of parkinsonism in monkeys. Neuroscience 18: 817-822.
7. 7. ELLIS, J. E., L. D. BYRD, AND R. A. E. BAKAY. 1992. A method for quantitating motor deficits in a nonhuman primate following MPTP-induced hemiparkinsonism and co-grafting. Exp. Neurol. 115: 376-387.
8. 8. ELSWORTH, J. D., A. Y. DEUTCH, D. E. REDMOND JR., J. R. SLADEK JR., AND R. H. ROTH. 1986. Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine toxicity in subregions of the primate substantia nigra and striatum. Life Sci. 40: 193-202.
9. 9. ELSWORTH, J. D., A. Y. DEUTCH, D. E. REDMOND JR., J. R. SLADEK JR., AND R. H. ROTH. 1987. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF. Brain Res. 415: 293-299.
10. 10. ELSWORTH, J. D., A. Y. DEUTCH, D. E. REDMOND JR., J. R. SLADEK JR., AND R. H. ROTH. 1990. MPTP-induced parkinsonism: Relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area, and retrorubral field of symptomatic and asymptomatic vervet monkeys. Brain Res. 513: 320-324.
11. 11. ELSWORTH, J. D., A. Y. DEUTCH, D. E. REDMOND JR., J. R. TAYLOR, J. R. SLADEK JR., AND R. H. ROTH. 1989. Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: Biochemical changes in striatal regions. Neuroscience 33: 323-331.
12. 12. HUANG, S. C., J. R. BARRIO, D. C. YU, B. CHEN, S. GRAFTON, W. P. MELEGA, J. M. HOFFMAN, N. SATYAMURTHY, J. C. MAZZIOTTA, AND M. E. PHELPS. 1991. Modelling approach for separating blood time-activity curves in positron emission tomographic studies. Phys. Med. Biol. 36: 749-761.
13. 13. HUANG, S. C., D. C. YU, J. R. BARRIO, S. GRAFTON, W. P. MELEGA, J. M. HOFFMAN, N. SATYAMURTHY, J. C. MAZZIOTTA, AND M. E. PHELPS. 1991. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies. J. Cereb. Blood Flow Metab. 11: 898-913.
14. 14. KURLAN, R., M. H. KIM, AND D. M. GASH. 1991. The time course and magnitude of spontaneous recovery of parkinsonism produced by intracarotid administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to monkeys. Ann. Neurol. 29: 677-679.
15. 15. LANGSTON, J. W. 1985. MPTP neurotoxicity: An overview and characterization of phases of toxicity. Life Sci. 36: 201-206.
16. 16. LEENDERS, K. L., W. H. POEWE, A. J. PALMER, D. P. BRENTON, AND R. S. J. FRACKOWIAK. 1985. Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by PET. Ann. Neurol. 20: 258-262.
17. 17. LUXEN, A., M. MONCLUS, P. HENDRICKX, AND C. MASSON. 1993. Synthesis and HPLC separation of 6-fluoro-L-DOPA metabolites. Bull. Soc. Chim. Belg. 103: 217-225.
18. 18. LUXEN, A., M. PERLMUTTER, G. T. BIDA, G. VAN MOFFAERT, J. S. COOK, N. SATYAMURTHY, M. E. PHELPS, AND J. R. BARRIO. 1990. Remote, semiautomated production of 6-[18F]-fluoro-L-dopa for human studies with PET. Int. J. Radiat. Appl. Instrum. Part A, Appl. Radiat. Isot. 41: 275-281.
19. 19. MELEGA, W. P., A. LUXEN, M. M. PERLMUTTER, C. H. NISSENSON, M. E. PHELPS, J. R. BARRIO. 1990. Comparative in vivo metabolism of 6-[18F]fluoro-L-DOPA and [3H]L-DOPA in rats. Biochem. Pharmacol. 39: 1853-1860.
20. 18F]fluoro-L-dopa in rats, monkeys and humans. Life Sciences, 47: 147-157.
21. 21. MELEGA, W. P., S. T. GRAFTON, S-C. HUANG, N. SATYAMURTHY, M. E. PHELPS, AND J. R. BARRIO. 1991. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: Biochemical parameters for the formulation of tracer kinetic models with positron emission tomography. J. Cereb. Blood Flow Metab. 11: 890-897.
22. 22. MELEGA, W. P., J. M. HOFFMAN, J. S. SCHNEIDER, M. E. PHELPS, AND J. R. BARRIO. 1991. 6-[18F]fluoro-L-dopa metabolism in MPTP-treated monkeys: Assessment of tracer methodologies for positron emission tomography. Brain Res. 543: 271-276.
23. 23. MELEGA, W. P., J. QUINTANA, M. J. RALEIGH, D. B. STOUT, D-C YU, K-P LIN, S-C. HUANG, M. E. PHELPS. 1996. FDOPA-PET shows partial reversibility of long-term effects of chronic amphetamine in monkeys. Synapse 22: 63-69.
24. 24. MORATALLA, R., B. QUINN, L. E. DELANNEY, I. IRWIN, AND J. W. LANGSTON. 1992. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Nat. Acad. Sci. 89: 3859-3863.
25. 25. PATE, B. D., T. KAWAMATA, T. YAMADA, E. G. MCGEER, K. A. HEWITT, B. J. SNOW, T. J. RUTH, AND D. B. CALNE. 1993. Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices. Ann. Neurol. 34: 331-338.
26. 26. PATLAK, C. S. AND R. G. BLASBERG. 1985. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J. Cereb. Blood Flow Metab. 5: 584-590.
27. 27. PATLAK, C. S., R. G. BLASBERG, AND J. D. FENSTERMACHER. 1983. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3: 1-7.
28. 28. PRZEDBORSKI, S., V. JACKSON-LEWIS, S. POPILSKIS, V. KOSTIC, M. LEVIVIER, S. FAHN, AND J. L. CADET. 1991. Unilateral MPTP-induced parkinsonism in monkeys. Neurochirugie 37: 377-382.
29. 29. RALEIGH, M. J. AND M. T. MCGUIRE. 1994. Serotonin, aggression and violence in vervet monkeys. In The Neurotransmission Revolution (R. Master and M. T. McGuire, Eds.), pp. 75-92. S. Illinois Univ. Press. Carbondale, IL.
30. 30. SCHNEIDER, J. S., W. W. MCLAUGHLIN, AND D. P. ROELTGEN. 1992. Motor and nonmotor behavioral deficits in monkeys made hemiparkinsonian by intracarotid MPTP infusion. Neurology 42: 1565-1572.
31. 31. SMITH, R. D., Z. ZHANG, R. KURLAN, M. MCDERMOTT, AND D. M. GASH. 1993. Developing a stable bilateral model of parkinsonism in rhesus monkeys. Neuroscience 52: 7-16.
32. 32. SNOW, B. J., I. TOOYAMA, E. G. MCGEER, T. YAMADA, D. B. CALNE, H. TAKAHASHI, AND H. KIMURA. 1993. Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels. Ann. Neurol. 34: 324-330.
33. 33. STRUHSAKER, T. T. 1967. Behavior of vervet monkeys (Cercopithecus aethiops). Univ. Calif. Publ. Zool. 82: 1-74.
34. 34. TAYLOR, J. R., J. D. ELSWORTH, R. H. ROTH, J. SLADEK JR., AND D. E. REDMOND JR. 1990. Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Brain 113: 617-637.
35. 35. WOODS, R. P., S. R. CHERRY, AND J. C. MAZZIOTTA. 1992. Rapid automated algorithm for aligning and reslicing PET images. J. Comp. Assist. Tomogr. 16: 620-633.